Population
Young adults in an industrial population with rhinovirus illness.
Design
Cohort
Authors
Loading...
Antibody development after most rhinovirus cases supports immunity studies; leaves open vaccine correlates and duration of protection.
Serum neutralizing antibody develops following the majority of rhinovirus illnesses, which is important in preventing symptomatic infection.
Jack M. Gwaltney (1967) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: